Clinical Trials Network, Ohio Valley Node
临床试验网络,俄亥俄谷节点
基本信息
- 批准号:7498313
- 负责人:
- 金额:$ 95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-30 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:14 year oldAIDS preventionAIDS/HIV problemAbbreviationsAbsorbent PadsAbstinenceAccident and Emergency departmentAccountabilityAccountingAcetaldehydeAcquired Immunodeficiency SyndromeAcuteAddressAdhesivesAdministratorAdolescentAdolescent MedicineAdoptedAdoptionAdultAdverse drug effectAdverse effectsAdverse eventAdvertisingAfricanAfrican AmericanAftercareAgeAge-YearsAgreementAlaska NativeAlcohol abuseAlcohol consumptionAlcohol dependenceAlcohol or Other Drugs useAlcoholismAlcoholsAlgorithmsAll SitesAllelesAmendmentAmericanAmerican IndiansAmphetaminesAnatomyAngiographyAnguishAnimal BehaviorAnti-Anxiety AgentsAnticonvulsantsAntihypertensive AgentsAnxietyAppalachian RegionAppendixAppointmentAreaAsiansAttentionAuthorization documentationAuthorshipBackBaclofenBasic ScienceBeck depression inventoryBehaviorBehavior TherapyBehavioralBehavioral SciencesBilateralBiologicalBiomedical EngineeringBipolar DisorderBloodBlood Chemical AnalysisBlood PressureBostonBrainBudgetsBuprenorphineBupropionBurn injuryBusinessesCarbamazepineCarboxylic Ester HydrolasesCardiacCardiovascular DiseasesCardiovascular systemCaringCase ManagementCase Report FormCategoriesCaucasiansCaucasoid RaceCellular biologyCertificationChairpersonCharacteristicsCheek structureChemicalsChestChicagoChildCitiesClinicClinicalClinical ManagementClinical Practice GuidelineClinical ResearchClinical TrialsClinical Trials Data Monitoring CommitteesClinical Trials DesignClinical Trials NetworkCocaineCocaine DependenceCocaine UsersCodeCognitiveCognitive TherapyCollaborationsCommitCommittee MembersCommunicable DiseasesCommunicationCommunitiesCommunity PharmacyCommunity SurveysComorbidityComplexComplicationComputer HardwareComputer SystemsComputer softwareConcept ReviewConditionConduct Clinical TrialsConnecticutConsensusConsentConsent FormsConsultationsContact InfoContractsControl GroupsCounselingCountCountryCountyCrack CocaineCriminal JusticeCrisis InterventionCultural DiversityCutaneousCytosineDSM-IVDailyDataData AnalysesData CollectionData ReportingDatabasesDay CareDeath RateDecision MakingDedicationsDependenceDependencyDepressed moodDetoxDevelopmentDevelopment PlansDevelopment, OtherDiagnosisDiagnosticDictionaryDiethyldithiocarbamateDiffusionDiffusion of InnovationDisadvantagedDisciplineDiseaseDistantDisulfiramDizzinessDoctor of MedicineDoctor of PhilosophyDocumentationDomestic ViolenceDopamineDopamine-beta-monooxygenaseDoseDouble-Blind MethodDropsDrowsinessDrug AddictionDrug CourtsDrug KineticsDrug Metabolic DetoxicationDrug MonitoringDrug abuseEating DisordersEconomicsEducationEducational StatusEffectivenessEffectiveness of InterventionsElectrocardiogramElectrophysiology (science)ElementsEligibility DeterminationEmploymentEncapsulatedEnrollmentEnsureEnvironmentEnzymesEquationEquilibriumEquipment and supply inventoriesEthanolEthnic OriginEthnic groupEuphoriaEvaluationEvidence based practiceEvidence based treatmentEvolutionExcisionExclusion CriteriaExpenditureExposure toFaceFacultyFamilyFamily memberFamily psychotherapyFeedbackFeesFemaleFemale AdolescentsFloridaFlushingFosteringFoundationsFrequenciesFundingFutureGABA ReceptorGamblingGenderGender IssuesGenerationsGeneric DrugsGenesGeneticGenetic PolymorphismGeographic LocationsGhettoGoalsGoverning BoardGrantGraphGray unit of radiation doseGroup MeetingsGuidelinesHIVHIV InfectionsHalf-LifeHandHaplotypesHeadHeadacheHealthHealth PersonnelHealth ServicesHearingHearing Impaired PersonsHeartHeart DiseasesHeart RateHematologyHepaticHepatitis CHepatotoxicityHeroinHeroin DependenceHispanicsHomelessnessHornsHourHousingHumanHuman GeneticsHuman ResourcesHuman immunodeficiency virus testHuntington DiseaseHypnotics and SedativesHypotensionIllinoisImageImmersion Investigative TechniqueImprisonmentIncentivesIncidenceIndianaIndividualInformation TechnologyInformed ConsentIngestionInpatientsInstitute of Medicine (U.S.)InstitutionInstructionInsuranceIntakeInterest GroupInternationalInternetInterventionInterviewInterviewerInvestigationInvestigational New Drug ApplicationIowaJailJob DescriptionJointsJudgmentKentuckyKetoconazoleKnowledgeLabelLaboratoriesLaboratory StudyLanguageLawsLeadLeadershipLeftLettersLevetiracetamLicensingLifeLimesLinear ModelsLiteratureLiverLiver Function TestsLocationLong IslandLow incomeMagnetic Resonance ImagingMagnetismMailsMaintenanceMaintenance TherapyManualsMarijuanaMeasurementMeasuresMedicaidMedicalMedical StaffMedical centerMedication ManagementMedicineMental DepressionMental HealthMentally Ill PersonsMentorsMetabolismMethadoneMethodologyMethodsMethyl GreenMethylphenidateMetyraponeMexicoMinnesotaMinorMinorityMissionMississippiMissouriMixed Function OxygenasesModafinilModalityModelingMolecular and Cellular BiologyMonitorMonitoring Clinical TrialsMorphineMothersMotivationMulti-Institutional Clinical TrialMycosesNaloxoneNaltrexoneNamesNational Institute of Drug AbuseNative AmericansNauseaNetwork-basedNeurobiologyNeurologicNeurosciencesNew YorkNickelNicotineNorepinephrineNumbersObject AttachmentOffice of Administrative ManagementOhioOperative Surgical ProceduresOpiate AddictionOpiatesOpioidOpioid ReceptorOregonOutcomeOutcome MeasureOutpatientsOxygenPI protocolPTGS1 genePacific Island AmericansPainPan GenusPanicPaperParanoiaParent-Child RelationsParticipantPathway interactionsPatient AdmissionPatient CarePatient Self-ReportPatient currently pregnantPatientsPediatric HospitalsPediatricsPerformancePersonal SatisfactionPersonsPharmaceutical PreparationsPharmacistsPharmacologic SubstancePharmacological TreatmentPharmacologyPharmacy facilityPhasePhysician ExecutivesPhysiciansPhysiologicalPlacebo ControlPlacebosPlasmaPlayPoliciesPopulationPositioning AttributePovertyPregnancy TestsPregnant WomenPrejudicePreparationPreventionPrevention educationPrevention interventionPrevention programPrincipal InvestigatorPrisonerProceduresProcessProductivityProgress ReportsPropertyProtocol ComplianceProtocols documentationProviderPsychiatristPsychiatryPsychological reinforcementPsychologyPsychometricsPsychotherapyPublic HealthPublicationsPublished CommentPublishingPurposeQualifyingRPS19 geneRaceRainRandomizedRandomized Clinical TrialsRandomized Controlled Clinical TrialsRandomized Controlled TrialsRangeRateReactionReadinessReadingReceptor GeneRecoveryRecruitment ActivityRegulatory AffairsRelapseReportingReproductive HealthReproductive Health ServicesResearchResearch ActivityResearch DesignResearch Ethics CommitteesResearch InfrastructureResearch PersonnelResearch TrainingReserpineResidential TreatmentResistanceResolutionResourcesReview CommitteeRewardsRiboflavinRightsRiotsRiskRisk BehaviorsRisk ReductionRisk-TakingRiversRoleRole playing therapyRouteRunningRuralSafetySample SizeSamplingSavingsScheduleSchoolsScienceScoreScreening procedureSecureSelection CriteriaSelegilineSelf-AdministeredSeriesSerious Adverse EventSertralineServicesSevere Adverse EventSeveritiesSeverity of illnessSexually Transmitted DiseasesShippingShipsSignal TransductionSingle Nucleotide PolymorphismSiteSite VisitSkinSleeplessnessSlideSmokingSoftware EngineeringSolidSolutionsSourceSpecific qualifier valueSpecificitySpectrum AnalysisStagingStandards of Weights and MeasuresStructureStudentsStudy SubjectSubstance AddictionSubstance Use DisorderSubstance abuse problemSupervisionSurveysSweatSweatingSyndromeSystemTabletsTarget PopulationsTattooingTechniquesTechnologyTechnology TransferTeleconferencesTelefacsimileTelephoneTerminologyTestingTextTherapeutic community techniqueThinkingThird-Party PayerThymineTimeTime StudyTimeLineTinTitleTobaccoTobacco DependenceTouch sensationToxic effectToxicologyTrainers TrainingTrainingTraumaTreatment ProtocolsTreatment outcomeTurtlesUcaUltraviolet RaysUnemploymentUnited StatesUnited States Food and Drug AdministrationUnited States National Institutes of HealthUnited States Substance Abuse and Mental Health Services AdministrationUniversitiesUpdateUpper armUrban PopulationUrinalysisUrineVariantVeteransVigabatrinVisionVisitVotingWagesWashingtonWaterWeekWest VirginiaWisconsinWomanWorkWorld Health OrganizationWritingY baseYouthacamprosateaddictionagedalcohol abuse therapyalcohol and other drugalcohol researchbasebenzoylecgoninebirth controlblindcaN protocolcarboxylesterasecare systemschild bearingchild protective servicecigarette smokingclinical efficacyclinical research siteclinically relevantclinically significantcocaethylenecohortcollegecommunity based servicecompliance behaviorcomputer monitorcomputerized data processingconceptcontingency managementcostcravingcyclooxygenase 1data integritydata managementdatabase designdaydemographicsdesigndonepezildosagedrinkingdrug abuserdual diagnosisdysphoriaecgonine methyl esterethnic minority populationexperiencefallsfightingfollow-upgabapentingroup counselinghealth care service utilizationhigh schoolhuman subjecthypnoticimprovedindexinginnovationinsightinstrumentinterestlamotriginemalemedication compliancemembermenmen who have sex with menmethadone clinic/centermetropolitanmotivational enhancement therapymu opioid receptorsmutantnamed groupneurochemistryneuroimagingneutrophiloffenderorganizational structureoutreachoxcarbazepinepeginterferon alfa-2bplacebo controlled studypregnancy hypertensionpreventprobationprofessorprogramsprotocol developmentpsychosocialquality assuranceresearch and developmentresearch studyresponsesafer sexsatisfactionsexsizeskillssmoking cessationsocialspecial interest groupstatisticssubstance abusersuccesssymposiumtherapy developmenttiagabinetooltopiramatetraining projecttransmission processtreatment centertreatment durationtreatment programtrendvalproatevolunteervoucherwastingwillingness
项目摘要
The Ohio Valley Node (OVN) joined NIDA's Clinical Trials Network (CTN) four years ago, as one of the CTN's
second wave of grantees. From the very beginning, the OVN has been a highly effective, enthusiastic, and energetic
node that has excelled in providing scientific and administrative leadership, in collaborating with other nodes andwith
NIDA staff, and in disseminating informationabout evidence-based practice and the results of CTN studies. Moreover,
the OVN has developed a model bi-directional relationship between its University of Cincinnati-affiliated Regional
Research and Training Center (RRTC) and its six original ("core") community treatment programs (CTPs), which are
located in Ohio, Indiana, Kentucky, and West Virginia.
In this continuation application, the OVN proposes to enhance the geographical and cultural diversity of the CTN by
expanding the OVN's Midwestern and Appalachian presence in the network and adding a Mississippi Delta component,
via nine additional "protocol-specific" CTPs in five additional states. The fifteen OVN CTPs, which together treat more
than 52,000 patients a year, will contribute significantly to the number and variety of potential participants for CTN
studies. Each of the core OVN CTPs has participated in at least one CTN clinical trial and two survey studies., and all
six will continue to share in the administration of the node and in its development of research concepts and protocols.
Although the new protocol-specific CTPs will play a more limited role, they are looking forward with enthusiasm to
participating in appropriate clinical trials, providing an expanded and enriched patient population to the CTN.
During the OVN's first four years in the CTN, we have immersed ourselves fully in all of its activities. We have
submitted nine protocol concepts, of which five were chosen for further development; two have been converted into full
protocols, including one which is currently enrolling participants. We have been active in the national committees of
the CTN, providing five committee chairs and authoring or contributing to many SOPs and "guidance" documents.
Unique contributions by the OVN include a system used CTN-wide for monitoring and reporting on staff training
requirements and accomplishments, a system for tracking the progress of CTN clinical trials, and a template used to
standardize the organization of CTN node budgets. The sense of satisfaction we feel in these and other
accomplishments, together with the urgency we feel to continue working on the important search for effective
reatments for substance abuse, make us eager to continue the work we have begun.
俄亥俄山谷节点(OVN)四年前加入了NIDA的临床试验网络(CTN),成为CTN的一员
第二波受赠者。从一开始,OVN就是一个高效、热情、充满活力的
在提供科学和管理领导、与其他节点协作和
NIDA工作人员,以及传播关于循证做法和CTN研究结果的信息。此外,
OVN在其辛辛那提大学附属地区之间建立了一种典型的双向关系
研究和培训中心(RRTC)及其六个原创(核心)社区治疗计划(CTP),这六个项目是
位于俄亥俄州、印第安纳州、肯塔基州和西弗吉尼亚州。
在这项延续申请中,国家志愿人员组织提议通过以下方式加强国家警察的地理和文化多样性
扩大OVN在中西部和阿巴拉契亚地区的网络存在,并增加密西西比三角洲的组成部分,
通过另外五个州的九个额外的“特定于协议的”CTP。15个OVN CTP,它们加在一起治疗更多
每年超过52,000名患者,将极大地促进CTN潜在参与者的数量和种类
学习。每个核心OVN CTP至少参与了一项CTN临床试验和两项调查研究,以及所有
Six将继续参与该节点的管理及其研究概念和协议的制定。
尽管新的特定于议定书的CTP将发挥更有限的作用,但他们热情地期待着
参与适当的临床试验,为CTN提供扩大和丰富的患者群体。
在OVN在CTN的头四年里,我们完全沉浸在它的所有活动中。我们有
提交了9个议定书概念,其中5个被选作进一步发展;2个已转化为完整概念
协议,包括一项目前正在招募参与者的协议。我们一直活跃在全国委员会中
CTN提供了五名委员会主席,并编写或促成了许多标准作业程序和“指导”文件。
OVN的独特贡献包括在CTN范围内用于监测和报告工作人员培训的系统
要求和成果,用于跟踪CTN临床试验进展的系统,以及用于
规范CTN节点预算组织。我们在这些和其他方面感受到的满足感
成就,以及我们感到的紧迫性,继续努力重要地寻求有效的
对药物滥用的治疗,使我们渴望继续我们已经开始的工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EUGENE C. SOMOZA其他文献
EUGENE C. SOMOZA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EUGENE C. SOMOZA', 18)}}的其他基金
Multisite Controlled Trial of Cocaine Vaccine (2 of 6) Cincinnati Treatment Site
可卡因疫苗多中心对照试验(6 中的 2)辛辛那提治疗中心
- 批准号:
8225238 - 财政年份:2008
- 资助金额:
$ 95万 - 项目类别:
Multisite Controlled Trial of Cocaine Vaccine (2 of 6) Cincinnati Treatment Site
可卡因疫苗多中心对照试验(6 中的 2)辛辛那提治疗中心
- 批准号:
8271728 - 财政年份:2008
- 资助金额:
$ 95万 - 项目类别:
Multisite Controlled Trial of Cocaine Vaccine (2 of 6) Cincinnati Treatment Site
可卡因疫苗多中心对照试验(6 中的 2)辛辛那提治疗中心
- 批准号:
7514796 - 财政年份:2008
- 资助金额:
$ 95万 - 项目类别:
Multisite Controlled Trial of Cocaine Vaccine (2 of 6) Cincinnati Treatment Site
可卡因疫苗多中心对照试验(6 中的 2)辛辛那提治疗中心
- 批准号:
7683035 - 财政年份:2008
- 资助金额:
$ 95万 - 项目类别:
Clinical Trials Network, Ohio Valley Node U10DA013732
临床试验网络,俄亥俄谷节点 U10DA013732
- 批准号:
7983629 - 财政年份:2000
- 资助金额:
$ 95万 - 项目类别:
相似海外基金
HIV/AIDS prevention and intervention: HIV surveillance methods, Per-exposure prophylaxis eligibility and HIV/STI testing behaviours among a cohort of people living with HIV.
HIV/艾滋病预防和干预:HIV 感染者群体中的 HIV 监测方法、每次暴露预防资格和 HIV/STI 检测行为。
- 批准号:
495195 - 财政年份:2023
- 资助金额:
$ 95万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10013921 - 财政年份:2020
- 资助金额:
$ 95万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10181081 - 财政年份:2020
- 资助金额:
$ 95万 - 项目类别:
UCLA AIDS Prevention and Treatment Clinical Trials Unit
加州大学洛杉矶分校艾滋病预防和治疗临床试验单位
- 批准号:
10166309 - 财政年份:2020
- 资助金额:
$ 95万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10597008 - 财政年份:2020
- 资助金额:
$ 95万 - 项目类别:
International Traineeships in AIDS Prevention Studies (ITAPS)
艾滋病预防研究国际培训(ITAPS)
- 批准号:
10386931 - 财政年份:2020
- 资助金额:
$ 95万 - 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
- 批准号:
9921510 - 财政年份:2019
- 资助金额:
$ 95万 - 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
- 批准号:
9753631 - 财政年份:2019
- 资助金额:
$ 95万 - 项目类别:
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care among Adolescents Living with HIV in Botswana
减少耻辱感,改善博茨瓦纳艾滋病毒感染青少年的艾滋病毒/艾滋病预防、治疗和护理
- 批准号:
10265667 - 财政年份:2019
- 资助金额:
$ 95万 - 项目类别:
Closing the Gap: Involving Indigenous Elders and youth in HIV/AIDS prevention using participatory filmmaking
缩小差距:利用参与式电影制作让土著老年人和青年参与艾滋病毒/艾滋病预防工作
- 批准号:
364681 - 财政年份:2017
- 资助金额:
$ 95万 - 项目类别: